News
The breadth of data we’re presenting at upcoming medical conferences reflects the scientific rigor and clinical potential of IN8bio’s gamma-delta T cell platform,” said William Ho, CEO and co-founder, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback